Symrise Q3 2026: 5.3% organic sales growth and full-year outlook reaffirmed

Third-quarter performance

Symrise reported organic sales growth of 5.3% in Q3 2026, driven predominantly by volume, solid customer demand and easier year‑on‑year comparables. Group sales were €1,310 million in the quarter, and €3,850 million for the first nine months, representing 3.0% organic growth year‑to‑date.

Segment details

The Taste, Nutrition & Health segment delivered 5.2% organic growth in Q3 with Food & Beverage showing mid‑single‑digit growth (double‑digit in Naturals, high‑single‑digit in Sweet, mid‑single‑digit in Savory) and Pet Food returning to low‑single‑digit growth as price normalization in Pet Nutrition continued.

The Scent & Care segment grew 5.6% organically in Q3. Fragrance posted mid‑single‑digit growth (consumer fragrance high‑single‑digit), Care & Wellness returned to low‑single‑digit growth with strong Advanced Actives and Probiotics, while Aroma Molecules showed high‑single‑digit growth led by Menthol.

Capital allocation and portfolio moves

Symrise repurchased 4.3 million shares under a share buyback due to conclude on 30 October 2026, with repurchased shares to be cancelled after completion. The company completed the divestment of its Terpenes business, acquired Floral Concept and invested in Maison Lautier 1795 and organic capacity, including Aroma Molecules.

Outlook

Symrise reaffirmed full‑year 2026 guidance: organic sales growth of 2–4%, an adjusted EBITDA margin of 21.5–22.5% and an adjusted business free cash flow margin above 14%. The company expects Q4 growth to moderate from Q3 against higher comparables and the adjusted EBITDA margin to be in the lower half of the guided range due to reinvestments in IT, innovation and people.